SEMA4C is involved in oncogenic signaling and is a potential therapeutic target for invasive breast cancer [14, 18], hepatocellular carcinoma [17], glioma [19] and osteosarcoma [20]. The gene discussed is SEMA4C; the disease is osteosarcoma.